DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid ...

SILVER SPRING, Md.--(BUSINESS WIRE)--The American Society for Parenteral and Enteral Nutrition (ASPEN) and Fresenius Kabi announced today a new educational video series highlighting best practices for ...

No clinically significant cases of essential fatty acid deficiency were observed in short term pediatric clinical studies. The Food and Drug Administration (FDA) has expanded the approval of ...

The Food and Drug Administration on Friday approved a lipid injectable emulsion called Clinolipid for parenteral nutrition in adult patients. The medication is a source of calories and fatty acids for ...

The US Food and Drug Administration (FDA) yesterday approved a new intravenous nutritional product for adults to alleviate a shortage of such drugs, the agency announced. The product is lipid ...

In a recent press release, Fresenius Kabi has announced the release of the first and only FDA-approved lipid emultion to address nutritional needs of pediatric patients suffering from life-threatening ...

Purpose: The stability window of medium-chain triglyceride (MCT) and long-chain-triglyceride (LCT) lipid-based total nutrient admixtures (TNAs) was studied. Methods: Sixteen different admixtures were ...

Emulsions are two-phase systems consisting of a dispersed phase (the droplets or particles) and a continuous phase (liquid diluent like water). In the dispersed phase, droplet size is critically ...

Clinolipid provides calories and essential fatty acids for parenteral nutrition Expanded indication demonstrates Baxter’s continued commitment to meeting the diverse nutritional needs of patients, ...